While some types of thrombosis could be treated by a wide variety of such molecules [7], the only licensed drug for emergency thrombus lysis in ischemic stroke is recombinant tissue plasminogen activator administered to a patient intravenously. The gene discussed is PLAT; the disease is ischemic stroke.